Nisa Investment Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.22M | Buy |
51,235
+33,316
| +186% | +$2.32M | 0.01% | 487 |
|
|
2025
Q4 | $1.19M | Sell |
17,919
-20,529
| -53% | -$1.33M | ﹤0.01% | 771 |
|
|
2025
Q3 | $2.59M | Sell |
38,448
-10,005
| -21% | -$792K | 0.01% | 582 |
|
|
2025
Q2 | $4.23M | Buy |
48,453
+14,225
| +42% | +$1.12M | 0.02% | 451 |
|
|
2025
Q1 | $2.34M | Sell |
34,228
-40,004
| -54% | -$3.26M | 0.01% | 596 |
|
|
2024
Q4 | $5.77M | Buy |
74,232
+13,867
| +23% | +$1.03M | 0.02% | 417 |
|
|
2024
Q3 | $4.05M | Sell |
60,365
-8,095
| -12% | -$665K | 0.02% | 479 |
|
|
2024
Q2 | $7.76M | Buy |
68,460
+9,092
| +15% | +$1.15M | 0.05% | 329 |
|
|
2024
Q1 | $8.23M | Sell |
59,368
-2,363
| -4% | -$297K | 0.05% | 314 |
|
|
2023
Q4 | $7.66M | Sell |
61,731
-2,190
| -3% | -$224K | 0.05% | 302 |
|
|
2023
Q3 | $5.96M | Sell |
63,921
-12,477
| -16% | -$1.41M | 0.05% | 356 |
|
|
2023
Q2 | $9.82M | Buy |
76,398
+16,686
| +28% | +$2.02M | 0.07% | 269 |
|
|
2023
Q1 | $6.94M | Buy |
59,712
+2,993
| +5% | +$335K | 0.05% | 325 |
|
|
2022
Q4 | $6.42M | Buy |
56,719
+236
| +0.4% | +$25.9K | 0.05% | 362 |
|
|
2022
Q3 | $4.69M | Buy |
56,483
+9,099
| +19% | +$771K | 0.04% | 390 |
|
|
2022
Q2 | $3.53M | Buy |
47,384
+740
| +2% | +$67.5K | 0.03% | 479 |
|
|
2022
Q1 | $5.97M | Buy |
46,644
+2,384
| +5% | +$261K | 0.04% | 366 |
|
|
2021
Q4 | $4.76M | Buy |
44,260
+236
| +0.5% | +$33.9K | 0.04% | 414 |
|
|
2021
Q3 | $6.02K | Sell |
44,024
-2,204
| -5% | -$278K | 0.04% | 391 |
|
|
2021
Q2 | $4.93K | Sell |
46,228
-9,800
| -17% | -$941K | 0.03% | 448 |
|
|
2021
Q1 | $5.03K | Sell |
56,028
-2,160
| -4% | -$203K | 0.03% | 445 |
|
|
2020
Q4 | $5.38M | Sell |
58,188
-1,184
| -2% | -$106K | 0.03% | 427 |
|
|
2020
Q3 | $6.12M | Sell |
59,372
-4,836
| -8% | -$505K | 0.05% | 326 |
|
|
2020
Q2 | $6.51M | Buy |
64,208
+22,760
| +55% | +$2.04M | 0.06% | 289 |
|
|
2020
Q1 | $2.79M | Buy |
41,448
+33,600
| +428% | +$2.09M | 0.03% | 439 |
|
|
2019
Q4 | $429K | Sell |
7,848
-6,412
| -45% | -$304K | ﹤0.01% | 1139 |
|
|
2019
Q3 | $532K | Buy |
14,260
+3,260
| +30% | +$127K | ﹤0.01% | 1072 |
|
|
2019
Q2 | $412K | Buy |
11,000
+460
| +4% | +$14.5K | ﹤0.01% | 1140 |
|
|
2019
Q1 | $314K | Sell |
10,540
-1,956
| -16% | -$68.7K | ﹤0.01% | 1187 |
|
|
2018
Q4 | $374K | Hold |
12,496
| – | – | ﹤0.01% | 1080 |
|
|
2018
Q3 | $447K | Buy |
+12,496
| New | +$387K | ﹤0.01% | 1133 |
|
|
2017
Q2 | – | Sell |
-1,040
| Closed | -$22K | – | 1843 |
|
|
2017
Q1 | $22K | Sell |
1,040
-960
| -48% | -$18.7K | ﹤0.01% | 1488 |
|
|
2016
Q4 | $30K | Hold |
2,000
| – | – | ﹤0.01% | 1516 |
|
|
2016
Q3 | $44K | Sell |
2,000
-1,200
| -38% | -$26.7K | ﹤0.01% | 1418 |
|
|
2016
Q2 | $63K | Hold |
3,200
| – | – | ﹤0.01% | 1372 |
|
|
2016
Q1 | $54K | Buy |
+3,200
| New | +$53.5K | ﹤0.01% | 1388 |
|
Other funds holding DXCM
VCM
VPM
Nisa Investment Advisors's DXCM Position: Q1 2026 in Review
Nisa Investment Advisors increased its DexCom (DXCM) stake by 186% in Q1 2026, buying an estimated $2.32M and bringing the position to 51,235 shares worth $3.22M. The position accounts for 0.01% of the portfolio, ranked #487.
Nisa Investment Advisors first reported a position in DXCM in Q1 2016 and has held it in 36 quarters since. The position peaked at $9.82M in Q2 2023. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Nisa Investment Advisors held 51,235 shares of DexCom worth $3.22M as of Q1 2026.
- Nisa Investment Advisors bought 33,316 DexCom shares in Q1 2026, an estimated $2.32M.
- DexCom made up 0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #487 holding.
- Nisa Investment Advisors first reported a position in DexCom in Q1 2016 and has held it in 36 quarters since.
- Nisa Investment Advisors's DexCom position peaked at $9.82M in Q2 2023.
- 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.